期刊文献+

晚期胆系肿瘤患者预后因素分析

The prognostic factors of advanced biliary cancers
下载PDF
导出
摘要 目的探讨影响晚期胆系肿瘤的预后因素。方法回顾性收集2015年12月至2019年12月收治住院的晚期胆系肿瘤患者,收集经组织和病理学或影像学确诊过的临床资料,将数据输入SPSS 22.0软件进行分析,生存的分析我们采用Kaplan-Meier(log-rank法),采用cox比例风险回归模型将含有统计学意义的单因素影响因子纳入进行多因素分析。结果本研究初步表明,影响晚期胆系肿瘤患者PFS的因素有:一线化疗方案是否含有吉西他滨,CA199水平,影响患者OS的因素有:一线化疗方案是否含有吉西他滨,CA199水平,NLR和RDW水平。结论化疗方案中不含吉西他滨、CA199、NLR及RDW高,可能是影响晚期胆系肿瘤患者的预后因素。 Objective To explore the prognostic factors of advanced biliary cancers.Methods We recruited patients from our hospital,between December 2015 and December 2019,who had advanced biliary tract cancers.Clinical and pathological data were collected and analyzed,using SPSS 22.0 software.Kaplan-Meier drawing method of progression free survival(PFS)and overall survival(OS)survival curve was adopt.COX regression model was applied for multivariate survival analysis.Results Risk factors for PFS:Gemcitabine,CA199.Risk factors for OS:Gemcitabine,NLR,RDW.Conclusion gemcitabine not included in the first-line chemotherapy regimen,CA199,NLR and RDW which may be the prognostic factors for patients with advanced biliary cancers.
作者 朱艳哲 郝吉庆 卜丽佳 宁洁 马泰 孙国平 ZHU Yan-zhe;HAO Ji-qing;PU Li-jia(The First Hospital of Anhui Medical University,Hefei 230022,China)
出处 《肝胆外科杂志》 2020年第4期270-274,共5页 Journal of Hepatobiliary Surgery
关键词 胆系肿瘤 预后因素 biliary cancers prognostic factors
  • 相关文献

参考文献4

二级参考文献56

  • 1刘颖斌,何小伟,王建伟,李江涛,李克强,刘付宝,薛建锋,朱锦辉,李兵,彭淑牖.胆囊癌肝转移模型的建立和高转移细胞亚群的筛选[J].中华医学杂志,2006,86(30):2117-2121. 被引量:8
  • 2Nikolas Tsavaris,Christos Kosmas,Panagiotis Gouveris,Kostadinos Gennatas,Aris Polyzos,Despina Mouratidou,Heracles Tsipras,Helias Margaris,George Papastratis,Evanthia Tzima,Nikitas Papadoniou,Gavrilos Karatzas,Efstathios Papalambros.Weekly Gemcitabine for the Treatment of Biliary Tract and Gallbladder Cancer[J]. Investigational New Drugs . 2004 (2)
  • 3M. Penz,G. V. Kornek,M. Raderer,H. Ulrich-Pur,W. Fiebiger,A. Lenauer,D. Depisch,G. Krauss,B. Schneeweiss,W. Scheithauer.Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer[J]. Annals of Oncology . 2001 (2)
  • 4Okada S,Ishii H,Nose H,Yoshimori M,Okusaka T,Aoki K,et al.A phase Ⅱ study of cisplatin in patients with biliary tract carcinoma. Oncology . 1994
  • 5Harvey JH,Smith FP,Schein PS.5-fluorouracil, mitomycin and doxorubicin (FAM) in carcinoma of the biliary tract. Journal of Clinical Oncology . 1984
  • 6Pitt HA,Dooley EC,Yeo CJ,et al.Malignancies of the biliary tree. Current Problems in Surgery . 1995
  • 7Misra S,Chaturvedi A,Misra NC,Sharma ID.Carcinoma of the gallbladder. The Lancet Oncology . 2003
  • 8Metzger J,Sauerbruch T,Ko Y,Wolter H,Funk C,Glas-macher A.A phase Ⅱ trial with gemcitabine in gallbhdder and biliary tract carcinomas. Onkologie . 1998
  • 9ValencakJ,Kornek GV,Raderer M,Ulrich-Pur H,Krauss G,Greul R, et al.Gemcitabine for the treatment of advanced biliary tract carcinomas: Evaluation of two different dose regimens. Onkologie . 1999
  • 10Greenlee RT,Hill-Harmon MB,Murray T,Thun M.Cancer Statistics. CA A Cancer Journal for Clinicians . 2001

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部